Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Medivie is an Israeli healthcare company specializing in medical cannabis and medical device technologies. The company's flagship medical device, Laborit, is a non-invasive solution designed to alleviate migraine symptoms and other pain-related conditions. Medivie has expanded its operations into the medical cannabis industry, focusing on the cultivation, production, and distribution of pharmaceutical-grade cannabis. Through its subsidiaries, the company aims to integrate advanced agricultural technologies with pharmaceutical standards to serve patients globally. Medivie is publicly traded on the Tel Aviv Stock Exchange under the symbol MDVI.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Medivie.